about
Blood and CSF biomarkers in brain subcortical ischemic vascular disease: Involved pathways and clinical applicabilityGRECOS Project (Genotyping Recurrence Risk of Stroke): The Use of Genetics to Predict the Vascular Recurrence After Stroke.Genetic variants in CETP increase risk of intracerebral hemorrhage.Dementia Rating Scale-2 normative data for middle-and older-aged Castilian speaking Spaniards.Blood biomarkers in cardioembolic stroke.Update on the Serum Biomarkers and Genetic Factors Associated with Safety and Efficacy of rt-PA Treatment in Acute Stroke Patients.High daytime and nighttime ambulatory pulse pressure predict poor cognitive function and mild cognitive impairment in hypertensive individualsN-glycome Profile Levels Relate to Silent Brain Infarcts in a Cohort of Hypertensives.Impaired visual evoked flow velocity response in cerebral amyloid angiopathyInvestigating silent strokes in hypertensives: a magnetic resonance imaging study (ISSYS): rationale and protocol design.Microbleeds versus macrobleeds: evidence for distinct entitiesPrevalence and associated factors of silent brain infarcts in a Mediterranean cohort of hypertensives.C-reactive protein predicts further ischemic events in transient ischemic attack patients.N-terminal pro-brain natriuretic peptide and subclinical brain small vessel disease.Oxidative stress after thrombolysis-induced reperfusion in human stroke.Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers.IL1B and VWF variants are associated with fibrinolytic early recanalization in patients with ischemic stroke.Endogenous activated protein C predicts hemorrhagic transformation and mortality after tissue plasminogen activator treatment in stroke patients.Obstructive sleep apnea and silent cerebral infarction in hypertensive individuals.Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: relationship to clinical and radiological outcome.Prevalence of hippocampal enlarged perivascular spaces in a sample of patients with hypertension and their relation with vascular risk factors and cognitive function.Short-Term Blood Pressure Variability Relates to the Presence of Subclinical Brain Small Vessel Disease in Primary Hypertension.In-hospital stroke: a multi-centre prospective registry.Letter by Riba-Llena et al regarding article, "Not listened or not reported rather than silent stroke".Brain natriuretic peptide is associated with worsening and mortality in acute stroke patients but adds no prognostic value to clinical predictors of outcome.Role of lipoprotein-associated phospholipase A2 activity for the prediction of silent brain infarcts in women.Semi-automatic measuring of arteriovenous relation as a possible silent brain infarction risk index in hypertensive patients.KCNK17 genetic variants in ischemic stroke.Upside down reversal of vision due to an isolated acute cerebellar ischemic infarction.Differentiating ischemic from hemorrhagic stroke using plasma biomarkers: the S100B/RAGE pathway.Plasma β-amyloid levels in cerebral amyloid angiopathy-associated hemorrhagic stroke.Quality of life and neurobehavioral changes in survivors of malignant middle cerebral artery infarction.Assessment of enlarged perivascular spaces and their relation to target organ damage and mild cognitive impairment in patients with hypertension.Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke.MMP-2/MMP-9 plasma level and brain expression in cerebral amyloid angiopathy-associated hemorrhagic stroke.Whole exome sequencing analysis reveals TRPV3 as a risk factor for cardioembolic stroke.Identification of Plasma Biomarkers of Human Intracerebral Hemorrhage Subtypes through Microarray Technology.The gender gap in stroke: a meta-analysis.Fas system activation in perihematomal areas after spontaneous intracerebral hemorrhage.ACE variants and risk of intracerebral hemorrhage recurrence in amyloid angiopathy
P50
Q28604099-E78FF7BE-3CF5-4336-AE62-4CA4A114D1EDQ30252625-6C6AD75D-8BE0-4B33-8FA0-AD9208FF7753Q30275688-212493DB-2E25-45E5-A11D-B38147D35C7AQ31095341-628849A9-B65A-4A05-930B-1AE1219C7A99Q34362880-B1520FA0-59C3-443D-9338-A6EE2DCBD4A4Q35109940-47A2ABFB-5D7A-47B0-BF4B-904910ECEC42Q36595854-5648B049-6A1C-448F-ABA2-ECA88E1DE314Q36836256-D398985D-0DE7-4941-B735-BE6047CB14CDQ37178995-58960E99-EAC8-4985-8E36-70A1FA924811Q37366209-7657DE8E-50A4-41B1-B970-93945AFF7472Q37378502-2A36F9D6-C536-4603-AF55-8BD4C30D8690Q39171169-D41A4947-AA29-4E8C-8ABC-0ED80288CB20Q40262287-A5FD644A-BE74-4AF2-AC0F-90DBBE68D10DQ40428201-0EB5A829-6EBE-45A1-991C-8BD239B6E5C5Q43149020-BA0C8269-F3C6-4C99-A8EF-E058FC14C07CQ43529232-483B15B8-46CF-4968-BD4F-706974FC602FQ44074071-9289BEA4-44B4-4C7A-A83D-BFA94BAFFDDDQ45201745-32C599F4-5A60-4074-9BD0-49233A064D0BQ47718697-B05987BA-E59F-4601-910B-A21E7C79233CQ47754161-1489EF79-FE0F-4952-8B5F-4619B589EF7CQ47869056-0203E2DD-92FB-4234-B68A-C2EC3181CA45Q48114750-C3D36D95-6088-40B4-BA91-648C3907ACEFQ48164973-9396E0DC-395F-41E9-B7EA-C65855055B50Q48205000-2E4B764F-3154-4E8A-90E7-96AE62ADBFB2Q48360592-36B5C5AD-B3CE-44E7-8C1C-5659252C283FQ48428338-D575DD4D-CD70-4C27-992F-DA531DAC3C2BQ48462105-09FE1115-08A5-44FB-B50E-B1332B384B90Q48496755-66213ACC-A8E9-4336-AADB-F5F82D2D1A57Q48581823-B17A8BFB-DE64-4DCB-904D-8F940E54BECEQ48655678-9E821D85-4EAD-4A78-8909-E032B27D5550Q48702297-7F2B9B25-5F85-4E7F-91F4-8CF115E88B23Q48704438-C0729F7F-F031-47AD-9A7E-0BCBB8157F11Q48840480-91257710-B43A-4EDC-9B30-ECD4910F2890Q48860486-17681051-8C96-48B6-ADE0-4740DD5DB534Q49122434-8A6F7A4B-3D61-4163-9DBB-7B43FE014F30Q50763838-360123CA-513E-4E31-9967-8E5D70019075Q52985873-B442B339-AB9A-48A7-973C-499D54389B6DQ53085093-814F0BEB-FF66-4922-BF97-C1C6A9D5E30FQ53423639-3F8AA6A8-ADCB-4844-AF18-67531283F651Q57495729-B4C10B9B-4708-4B1E-979C-79778D120136
P50
description
investigador
@es
neurology researcher
@en
name
Pilar Delgado
@en
Pilar Delgado
@nl
type
label
Pilar Delgado
@en
Pilar Delgado
@nl
altLabel
María Pilar Delgado Martínez
@en
prefLabel
Pilar Delgado
@en
Pilar Delgado
@nl
P106
P31
P496
0000-0002-1628-4488